# Quercetin prevent airway epithelial remodeling and promote lung health in OPD

> **NIH NIH R01** · TEMPLE UNIV OF THE COMMONWEALTH · 2022 · $451,265

## Abstract

PROJECT SUMMARY
Patients with chronic obstructive pulmonary disease often show airway epithelial remodeling including basal cell
hyperplasia, and goblet cell and squamous cell metaplasia. Such pathologic changes profoundly affect the
outcome of respiratory infection as airway epithelium plays a crucial role in defining the innate and adaptive
immunity in the lungs. Airway basal cells are the specialized stem cells and regenerate functional mucociliary-
differentiated airway epithelium upon injury. The fact that COPD patients show airway epithelial remodeling
indicate dysregulated repair mechanisms in airway basal cells. Our research suggests that quercetin, a natural
polyphenol reverses airway epithelial remodeling in a mouse model of COPD. Our preliminary studies indicate
that quercetin reprograms dysregulated repair pathways in COPD basal cells leading to regeneration of normal
airway epithelium. We conducted transcriptomic analysis of airway basal cells from healthy non-smokers and
COPD subjects and COPD basal cells treated with quercetin. Results from this microarray indicated
dysregulation of genes involved in tissue development and epithelial differentiation in COPD cells. Intriguingly,
the topmost differentially regulated genes in both these pathways are genes involved in lung morphogenesis
HOXA1 and HOXB2. In normal basal cells, HOXA1 is highly expressed in basal cells, while HOXB2 expression
increased at two weeks of culturing and correlated with polarization of cells, a prerequisite step in differentiation.
COPD basal cells showed significantly reduced expression of both HOXA1 and HOXB2 and quercetin treatment
increased expression of both genes. Based on these observations, we will examine a novel hypotheses that
quercetin via modulation of HOXA1 and HOXB2 corrects the dysregulated repair mechanisms, thus improving
immune responses to respiratory infections and lung function in COPD. In Specific Aim 1, we will determine the
role of HOXA1 and HOXB2 in the regeneration of airway epithelium, and whether quercetin corrects the
dysregulated repair mechanism in COPD by modulation of these HOX genes. In Specific Aim 2, we will examine
the molecular mechanisms by which quercetin-induced HOXA1 and HOXB2 participates in the regeneration of
airway epithelium. In Specific Aim 3, we will examine whether quercetin-induced HOXA1 and HOXB2 participate
in limiting exaggerated innate immune responses to rhinovirus infection and prevent progression of lung disease
in COPD. Finally, we will confirm whether quercetin treatment reduces airway epithelial remodeling in COPD
patients and correlate with the expression of HOXA1 and HOXB2. Completion of these studies will provide
important insight into airway epithelial regeneration and the mechanisms by which quercetin reduces airway
epithelial remodeling in COPD.

## Key facts

- **NIH application ID:** 10435564
- **Project number:** 5R01HL157258-02
- **Recipient organization:** TEMPLE UNIV OF THE COMMONWEALTH
- **Principal Investigator:** Umadevi Sivanappa Sajjan
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $451,265
- **Award type:** 5
- **Project period:** 2021-07-01 → 2025-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10435564

## Citation

> US National Institutes of Health, RePORTER application 10435564, Quercetin prevent airway epithelial remodeling and promote lung health in OPD (5R01HL157258-02). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10435564. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*